A Review of Mitomycin Use in Ophthalmic Surgery: Clarification of Safety Standards for Patients and Hospital Personnel-Reference-Cited by-同舟云学术

A Review of Mitomycin Use in Ophthalmic Surgery: Clarification of Safety Standards for Patients and Hospital Personnel

Published:2016-10-01 Issue:4 Volume:4 Page:187-197
ISSN:2167-4868
Container-title:Current Ophthalmology Reports
language:en
Short-container-title:Curr Ophthalmol Rep

Author:

Radke Phillip M.,Bitrian Elena,Kaufman Stephen C.,Grajewski Alana L.

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s40135-016-0111-2.pdf

Reference83 articles.

1. Wakaki S, Marumo H, Tomioka K, Shimizu G, Kato E, Kamada H, et al. Isolation of new fractions of antitumor mitomycins. Antibiot Chemother [Northfield, Ill]. 1958;8(5):228–40.

2. Doll DC, Weiss RB, Issell BF. Mitomycin: ten years after approval for marketing. J Clin Oncol. 1985;3(2):276–86.

3. Joshi AB, Parrish RK 2nd, Feuer WF. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma. 2005;14(2):172–4.

4. Koranyi G, Artzen D, Seregard S, Kopp ED. Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up. Acta Ophthalmol. 2012;90(3):266–70. doi: 10.1111/j.1755-3768.2010.01936.x .

5. Fernandes M, Reddy P, Shah SG. One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy [PRK] with mitomycin C [MMC] and laser in situ keratomileusis [LASIK]. Br J Ophthalmol. 2011;95(3):433. doi: 10.1136/bjo.2010.188151 .

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polysaccharide-Based Lotus Seedpod Surface-Like Porous Microsphere as an Efficient Drug Carrier for Cancer Treatment;Cancer Management and Research;2021-05